Clinical Trials Browser

Phase 2 × Melanoma × phosphomannopentaose sulfate × Clear all

NCT00130442 2022-06-23

Trial of PI-88 With Dacarbazine in Patients With Metastatic Melanoma

Phase 2 Completed

134 enrolled 16 charts

Melanoma